Immediate Outcome and Risk Factors Determining the Outcome of Status Epilepticus in Children Attending Tertiary Care Centre by Murali, T
 
 
 
 
IMMEDIATE  OUTCOME  AND RISK FACTORS DETERMINING 
THE OUTCOME OF  STATUS EPILEPTICUS 
IN CHILDREN ATTENDING TERTIARY CARE CENTRE 
 
 
 
DISSERTATION SUBMITTED FOR 
M.D DEGREE EXAMINATION  
BRANCH VII - PAEDIATRIC MEDICINE 
APRIL  2011 
 
 
 
TIRUNELVELI MEDICAL COLLEGE 
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY 
CHENNAI. 
 
 
 
 
 
CERTIFICATE 
 
This is to certify that the dissertation titled, “IMMEDIATE  OUTCOME  AND 
RISK FACTORS DETERMINING THE OUTCOME OF STATUS EPILEPTICUS IN 
CHILDREN ATTENDING TERTIARY CARE CENTRE”  submitted by Dr.T.Murali, to 
the Faculty of Paediatrics, The Tamilnadu Dr. M.G.R Medical University, Chennai, in partial 
fulfilment of the requirements for the award of  M.D. Degree (Paediatrics) is a bonafide 
research work carried out by him under our direct supervision and guidance, during the 
academic year 2009-2011. 
 
 
Dr. T.Kathir Subramaniyam. M.D.,D.C.H.,        Dr.T.Kathir Subramaniyam.  M.D.,D.C.H.,                                   
Unit Chief,                                                       Professor and Head, 
Department Of paediatrics,                              Department Of Paediatrics, 
Tirunelveli Medical College,                           Tirunelveli Medical College, 
Tirunelveli.                                                      Trunelveli. 
 
 
 
 
 
The Dean 
Tirunelveli Medical College, 
Tirunelveli. 
 
 
 
 
 
DECLARATION 
 
I, Dr.T.Murali, solemnly declare that the dissertation titled “IMMEDIATE  
OUTCOME  AND RISK  FACTORS  DETERMINING  OUTCOME OF  STATUS 
EPILEPTICUS IN CHILDREN ATTENDING TERTIARY CARE CENTRE”  has been 
conducted by me at Tirunelveli Medical college, Department of Pediatrics, Tirunelveli, 
during 2009-2011 under the guidance and supervision of my unit chief PROF.T.KATHIR 
SUBRAMANIYAM,M.D,D.C.H., This is submitted in partial  fulfilment of the award of the 
degree of M.D,(Pediatrics) for the April 2011 examination to be held under the Tamilnadu 
Dr. M.G.R. Medical University, Chennai .This study has not been submitted previously by 
me for the award of any degree or diploma from any other university. 
 
 
 
(Dr.T.MURALI.)  
M.D.Paediatric Medicine                                        
                                                                                    Postgraduate Student 
                                                                                    Tirunelveli Medical College 
                                                                                    Tirunelveli 
 
 
 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
I sincerely thank Dr. N. Palaniappan M.D., Dean, Tirunelveli MedicalCollege and 
Dr. Jimla Balachandran M.D., Medical Superintendent, Tirunelveli Medical College 
Hospital for permitting me to do this dissertation work in our hospital premises and for 
judiciously utilizing the various facilities instrumental to do this study.  
I am deeply indebted to the Professor of Pediatrics and Head of the Department, Unit 
Chief my guide and beloved teacher, Dr. T. Kathir Subramaniam, M.D., D.C.H., for the 
boundless affection, kind encouragement advice and valuable criticism given by him 
throughout the study. 
I sincerely thank our Chief, Dr. M. Devikala. M.D., D.C.H.,and                       
Dr.T. Ravichandran,M.D., D.C.H., for guiding me throughout the studies. 
I always regard with great gratitude to my Assistant Profs, Dr.T.R.R.Anandhyshri, 
M.D., Dr.L. Venketraman, M.D.,D.C.H., Dr.C. Baskar, M.D., D.C.H.,for the able guidance 
and assistance in doing this work. 
My humble gratitude to Dr. T. Viswanathan, M.D., Asst. Professor, for his able 
guidance and assistance in completing this study. 
I would like to thank Dr. Radha., M.D., D.M., Neurology, department of neurology, 
Tirunelveli Medical college ,Tirunelveli for extended support and guidance in doing this 
work. 
 I express my sincere thanks to Dr. Pedhuru. M.D., S.P.M., for his support, statistical 
analysis and guidance. 
I would like to thank all the children and their parents for their consent and 
participation in this study. 
                                                                       
 
 
 
 
CONTENTS 
SINO TITLE 
 
PAGE NO. 
1 INTRODUCTION 1 
2 STUDY JUSTFICATION  2 
3 REVIEW OF LITERATURE 3 
4 AIM AND OBJECTIVE 27 
5 MATERIALS AND METHODOLOGY 28 
6 RESULTS AND ANALYSIS 32 
7 DISCUSSION 49 
8 CONCLUSION 55 
9 SUMMARY   57 
10 ABBREVIATION  
11 PROFORMA  
 BIBLIOGRAPHY  
 MASTER CHART  
 
                         
 
 
 
 
 
 
1 
 
INTRODUCTION 
Status epilepticus (SE) is a paediatric and neurological medical emergency associated 
with significant morbidity and mortality. Status epilepticus represents the brains reaction to 
an acute insult or it may be a modification of already existing epilepsy. The mortality 
associated with SE  in children is considerable without treatment. Hence optimum 
management includes prompt recognition, appropriate therapy, and investigations for the 
cause of status epilepticus followed by correction. 
The incidence of status epilepticus has a bimodal distribution with peaks in children 
aged less than a year and the elderly. 
SE is defined as a continuous seizure lasting more than 30 min, or two or more 
seizures without full recovery of consciousness between any of them.1  However based on 
recent understanding of the pathophysiology, newer definition includes seizures that lasts 
more than 5 minutes needs to be treated as SE. If circulation is restored within 3-5 minutes, 
full recovery may occur, but if hypoxic-ischemia lasts beyond 3-5 minutes some degree of 
permanent cerebral damage is the rule. Status Epilepticus common in childhood, and the 
reported current mortality is in the range of 4-6% 2. The evolution of a prolonged seizure into 
Status Epilepticus is associated with increased morbidity and mortality. Hypoxia is currently 
thought to be responsible for most of the complications seen in Status Epilepticus3. SE in 
children is a life-threatening condition with serious risk of neurological sequelae. The 
outcome from an episode of SE is determined primarily by its cause, but the duration of the 
seizure and prompt, appropriate treatment are still extremely important contributing factors. 
Any type of seizure can lead to status epilepticus, but generalized tonic- clonic status 
epilepticus is the most common and most dangerous type. The longer seizures continue, the 
more difficult they are to control and the higher the morbidity and mortality. Permanent 
neuronal damage can occur after 60 minutes of seizure activity. 
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STUDY JUSTIFICATION 
 
  Status epilepticus is one of the most common paediatric and neurological 
emergencies. Status epilepticus is an under-recognized health problem associated with 
substantial morbidity and mortality. Data on outcome in status epilepticus in children is 
sparse in our country. 
Though we managed status epilepticus in our tertiary care level hospital we do come 
across poor outcome in SE. Mortality remain high due to longer duration of travel with 
prolonged SE, improper  prehospital therapy, refractory seizures, etiological factors and risk 
factors influencing the poor outcome. This study done to identify these risk factors for both 
death and neurological sequelae. 
If these determinant factors identified and managed aggressively and in a time bound 
manner, outcome of status epilepticus in children can be improved.  
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REVIEW OF LITERATURE 
 
Status epilepticus (SE) has been defined as continuous seizure activity lasting more 
than 30 min (or) 2 or more seizures in this duration without regaining consciousness in 
between them. However, the operational definition has brought the time down to 5 min. 
ETIOLOGY : 
The etiological factors that causes SE and affect the outcome of SE are febrile 
seizures, acute infections, trauma, metabolic derangements, drug overdose, hypoxia, 
idiopathic epilepsy, drug withdrawal, structural brain damage, static causes, degenerative 
disorder etc. 
ETIOLOGICAL CLASSIFICATION OF SE4 
TYPE DEFINITION EXAMPLES 
Remote symptomatic SE occurring without an 
acute provocation in a 
patient with a history of 
CNS insult 
CNS malformation, Previous traumatic 
brain injury or insult, chromosomal 
disorder 
Acute symptomatic SE occurring during an 
acute illness (e.g., acute 
CNS insult, acute 
encephalopathy) 
Meningitis, encephalitis, electrolyte 
disturbance, hypoxia, intoxication, 
sepsis, trauma 
Febrile SE occurring when the only 
provocation is a febrile 
illness, after excluding a 
direct CNS infection  
 
Upper respiratory infection, sinusitis, 
sepsis 
4 
 
 
PATHOPHYSIOLOGY : 
ACUTE SYSTEMIC AND CNS COMPLICATION:  
Acute systemic effects of GTCS include cardiovascular alteration, acidosis, 
respiratory distress, hyperthermia and renal failure secondary to rabdomyolysis. The 
physiological alteration occurs in two phases. 
PHASE I 
Initial phase last during the first 30 minutes of SE. This early phase is characterised 
by sympathetic overdrive. The systemic effects of CSE are initially dominated by the body’s 
attempt to maintain homeostasis.5 Blood pressure and central venous pressure increase, blood 
glucose increases, and the patient become tachycardic.6 Mean arterial pressure is elevated as 
Cryptogenic 
(Idiopathic) 
SE occurring in the absence 
of an acute precipitating 
CNS insult, systemic 
metabolic disturbance, or 
both 
No definable cause 
 
 
Progressive 
encephalopathy 
SE occurring with an 
underlying, progressive 
CNS disorder 
Amino or organic acidopathies, CNS 
lipid storage diseases, mitochondrial 
disorders 
Remote symptomatic 
with an acute 
precipitant 
SE occurring with a chronic 
encephalopathy, but with an 
acute provocation 
CNS malformation or 
previous CNS insult with 
concurrent infection, 
hypoglycemia, 
hypocalcemia, or 
intoxication 
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a result of increased vascular resistance. CSE may also result in electrolyte imbalance and 
hyperthermia7. Cerebral blood flow, blood glucose, and oxygen utilisation increase in the 
initial phases of a seizure to maintain cerebral homeostasis. 
PHASE II 
After 30 minutes homeostatic failure begins and the patient may need systemic 
support. Cerebral blood flow, brain glucose, and parenchymal oxygenation all decrease and 
potentially play a part in the cell damage associated with CSE6. Respiratory and metabolic 
acidosis, electrolyte imbalance (for example, hyperkalemia), hyperthermia, and 
rhabdomyolysis may all occur .Treatment with drugs having  depressant cardiorespiratory 
side effects (for example, benzodiazepines and barbiturates) may worsen the systemic 
complications of CSE. 
 
 
 
 
 
 
  
 
 
 
 
 SEIZURE DURATION‐ 30 MIN                MORE THAN 30 MIN 
                  PHASE 1 
SYMPATHETIC OVERDRIVE 
¾ Blood pressure and 
central venous 
pressure increase, 
blood glucose 
increases 
¾ Mean arterial 
pressure is elevated 
¾ Cerebral blood flow, 
blood glucose, and 
oxygen utilisation 
increased 
                  PHASE 2 
            EXHAUSTION 
¾ After 30 minutes 
homeostatic failure 
begins 
¾ Hypotension 
¾ Cerebral blood flow, 
brain glucose, and 
parenchymal 
oxygenation decreased 
¾ Metabolic acidosis 
¾ Electrolyte imbalance 
Neuronal cell damage 
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Temporal changes which occur as tonic-clonic status epilepticus progresses. Motor 
activity lessens, the electroencephalogram (EEG) evolves and profound physiological 
changes occur, both systematically and cerebrally. In the first 30 minutes or so, physiological 
changes are largely compensatory, but as the seizures continue these compensatory 
mechanisms break down. The biphasic evolution is emphasised periodic epileptic discharge 
(PED). 1, loss of reactivity of brain oxygen tension; 2, mismatch between the sustained 
increase in oxygen and glucose utilisation and a fall in cerebral blood flow; 3, a depletion of 
cerebral glucose and glycogen concentrations; 4, a decline in cerebral energy state.  
SEIZURE INITIATION AND PROLONGATION 
  Seizure initiation is caused by an imbalance between excitatory and inhibitory 
neurotransmission, leading to the initiation of abnormal neural impulses. The seizure 
threshold in the immature brain appears to be lower than in the mature brain, but the 
mechanisms that underlie this susceptibility remain unclear. Excitatory synapses mature 
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earlier than inhibitory synapses and this, coupled with an increase in the susceptibility of 
excitatory neurotransmitter receptors, increases the likelihood that an excitation–inhibition 
imbalance may occur8 9.  
There are other important differences between the immature and adult brain. 
Stimulation of GABAA receptors in the immature brain results in depolarisation rather than 
hyperpolarisation10 The immature cerebral cortex has a high synaptic density at around 2 
months of age and this may contribute to the development of hyper synchrony of neural 
groups9.  
The excitatory amino acid neurotransmitter glutamate increases at the site of the 
seizure focus at the beginning of seizure activity in adults with temporal lobe epilepsy when 
measured by in vivo intracerebral microdialysis11. It is believed that the same may happen at 
the onset of generalised seizures. Inhibitory neurotransmitters such as GABA later increase at 
the seizure focus and redress the balance between excitation and inhibition. GABA also 
increases in the substantia nigra, pars reticulata, an area that can modulate a cortical 
inhibitory response in adult rats, but not in immature rats. 
Other mechanisms of inhibitory receptor modulation, such as adenosine receptor 
agonist, may also contribute to seizure termination.  
ELECTROPHYSIOLOGY 
CSE starts with localised epileptic activity followed by isolated generalised bursts of 
seizure activity with a normal EEG in between. If the patient does not regain consciousness 
between these episodes, then they meet the clinical criteria for CSE. The isolated ictal 
discharges merge and become a continuous discharge after about 30 minutes. Discharges then 
fragment and are interspersed with flat periods. Ultimately, periodic epileptiform discharges, 
which may reflect underlying metabolic failure, will occur.5 12 
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The motor phenomena associated with CSE follow a similar pattern to the EEG 
changes. Recurrent seizures will merge into continuous motor activity, followed by 
fragmentation of the motor activity and myoclonus. If the seizure persists, then 
electromechanical dissociation will ensue. The prognosis for a good neurological outcome 
decreases the further the patient moves through this continuum. 
ROLE OF EXCITOTOXIC AMINO ACIDS IN THE DEVELOPMENT OF 
STRUCTURAL BRAIN DAMAGE SECONDARY TO CSE 
Mesial temporal sclerosis is the most common acquired brain lesion following CSE 
and may result from excitotoxicity. They suggested that glutamate was directly responsible 
for the cell death, although the neurotransmitter role of glutamate was unknown. Since that 
time much animal model and cell culture work has attempted to prove this hypothesis and to 
relate it to status epilepticus.13 Direct application of glutamate on to hippocampal cultures 
causes neuronal death.14 This work provides indirect evidence that CSE can itself cause 
hippocampal damage. 
CSE induces the production of heat shock proteins in several brain regions. The 
presence of heat shock proteins can protect the brain against further stressful stimuli, which 
are potentially damaging to neurones15. The implication is that prolonged seizures may need 
to occur in epilepsy human patients for mesial temporal sclerosis to develop, and that once it 
has developed further episodes of CSE may not worsen the mesial temporal sclerosis. 
MECHANISMS BY WHICH GLUTAMATE CAUSES CELL DEATH 
Excess extracellular glutamate may result in cell death by causing necrosis, gene 
determined cell death, or both. The primary receptor involved in cytotoxicity related to 
glutamate is the NMDA receptor, although other glutamate receptors may be involved.16  The 
NMDA receptor is an ionotropic receptor. Binding of glutamate and glycine or d-serine to 
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appropriate sites on the receptor results in an influx of calcium through the ionophore. High 
intracellular calcium concentrations result in  
• Activation of protein kinase C.   
• Nitric oxide and free radical formation. 
• Activation of phospholipase A2.  
• Activation of protease calpain I. Calpain inhibitors are partially neuroprotective. 
Glutamate receptor stimulation also results in the formation of immediate early genes, 
such as c-fos, fos-B, c-jun, and jun-B. c-fos encodes for Fos protein, which has a 
leucine zipper allowing it to bind and form dimers with similar proteins.17 Some of 
the genes regulated are harmful and some are potentially neuroprotective.  
  The potentially toxic effects of metabotropic glutamate activation include the 
potentiation of NMDA and other excitatory membrane currents, the potentiation of 
intracellular calcium release, a decrease in inhibitory membrane currents, and decreased 
GABAergic inhibition. Conversely, potential protective effects include the inhibition of 
synaptic glutamate release and decreased calcium influx.18 
  Children who develop CSE in the neonatal period do not appear to develop mesial 
temporal sclerosis, but others are most vulnerable under the age of 3 years. 
REFRACTORY STATUS EPILEPTICUS: 
RSE is defined as seizures that are not controlled with adequate doses of BZD, 
Phenytoin ,phenobarbitone and require more aggressive treatment.19Children with prior, 
neurological problem, progressive CNS injury, complications, refractory status epilepticus 
have poor outcome. Continous IV infusion of midazolam, propofol, sodium valproate, 
thiopentone sodium are the most useful treatments  
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NONCONVULSIVE STATUS EPILEPTICUS: 
This condition is recognised , when an unresponsive child presents with conjugate 
deviation of eyes, eyelid twitch, nystagmus or unilateral clonus. NCSE should be anticipated  
when a child is brought with history of seizures but has not regained baseline consciousness 
and does not have obvious convulsive activity.A high index of suspicion is needed to identify 
the NCSE during the course of management of CSE. Convulsive activity disappears but the 
child remains apneic or tachypneic, shocky and unresponsive. The eye signs indicate the 
persistence of ongoing seizure activity. Continuing aggressive management of the airway 
breathing and circulation with the same drug protocol of CSE will improve the outcome. 
TYPES OF STATUS EPILEPTICUS 
                                GCSE/     GTCS (primary) 
                                Secondary generalised 
                                 Multifocal clonic  
Hemiconvulsive SE 
Tonic SE 
Clonic SE 
Simple PSE/epilepsia partia continualis 
Non convulsive status epilepticus(Subtle SE) 
Neurological EMD(electrical SE) 
PCSE 
ASE 
Myoclonic SE+/- Salam attacks 
Complications of status epilepticus 20: 
1. Interictal coma. 
2. Cumulative anoxia- cerebral and systemic. 
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3. Cardiovascular complications – Tachycardia, Bradycardia, cardiac arrest, 
hypertension, cardiac failure, shock. 
4. Respiratory system failure- Apnea, Cheyne-stokes breathing, aspiration, pneumonia, 
tachypnea, neurogenic pulmonary oedema, pulmonary embolism, cyanosis, and 
respiratory acidosis. 
5. Renal failure- Oliguria, uremia, acute tubular necrosis, rhabdomyolysis. 
6. Autonomic disturbances – Hyperpyrexia, sweating, vomiting, hyper secretion, airway  
obstruction. 
7. Metabolic and Biochemical abnormalities – Acidosis (Metabolic, lactic acidosis), 
hyper and hyponatremia, hyperkalemia, hypoglycemia, hepatic failure, dehydration,  
acute pancreatitis. 
8. Infections- pulmonary, bladder. 
9. Others – Disseminated intravascular coagulation, multiple organ dysfunction, 
fractures, and thrombophlebitis. 
INVESTIGATIONS 
Complete blood count 
Blood sugar 
Serum calcium, electrolytes, 
CXR 
CT Brain /USG Cranium 
CSF analysis  
EEG, 
X-ray skull 
MRI 
Renal function test 
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Liver function test 
Serum magnesium 
Serum ammonia, lactate 
ABG 
Blood culture and sensitivity 
Toxicological screening 
AED Level in blood /urine 
Metabolic screening 
EEG  
        In a child with a new onset of seizures, an EEG may help to differentiate ictal from non 
ictal events, to determine seizure type or epilepsy syndrome and to better define the risk for 
recurrence. For most children it is not necessary to perform the EEG as part of the initial 
emergency department evaluation. In fact if it is performed shortly after the seizure (<48 
hours) the EEG may show diffuse post ictal slowing without prognostic significance. Among 
children with persistent altered mental status after a seizure an emergent EEG is helpful to 
identify subtle or NCSE. 
   NEURO IMAGING:   CT Brain may be necessary to evaluate safety of LP and to rule 
out haemorrhage or large mass lesions. MRI will almost always be performed later, even if 
CT is normal. 
Lumbar Puncture should be done if SE presented in febrile children. And it should be done 
only after stabilizing the child not at arrival. 
MANAGEMENT: 
Status epilepticus is a medical emergency that requires an organised and skillful 
approach to minimize the associated mortality and morbidity. longer the duration of seizures, 
greater the risk of complications. Hence protocol based therapy must be aggressive because 
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neuronal excitability can be reversed only early in the course and quick intervention may 
decrease the risk of seizures generated neuronal damage.  
CSE is an emergency and the fact that aetiology emerges as the most powerful 
predictor of outcome should not be read as meaning that interventions may not alter that 
outcome. The main objectives of treatment, which should be addressed simultaneously, are: 
a) Support of vital functions and oxygenation. 
b) Termination of seizure .      
c) Identification and treatment of causal or precipitating factors. 
a) SUPPORT OF VITAL FUNCTIONS AND OXYGENATION 
Treatment should follow the ABC principles of resuscitation in order to maintain 
airway, ventilation-oxygenation and blood pressure.  
AIRWAY AND BREATHING 
Open the airway using the head tilt and chin lift maneuver. C-spine precaution are 
taken if trauma is suspected gentle oropharangeal suction done .Oxygen is provided with the 
non-rebreathing mask .If the patient is not breathing a bag and mask ventilation is used to 
assist ventilation. If the patient is not ventilating  due to convulsion or is become cyanosed, 
the airway is secured using rapid sequential intubation technique. Continuous monitoring of 
vital signs, ECG and pulse oximetry are recommended. The airway, breathing and circulation 
take precedence over seizure control. Intermittent or persistent apnea is not a contraindication 
for AED but an indication for establishing airway and breathing. 
GLUCOSE 
Hypoglycemia can cause severe disruption of autoregulation of cerebral blood 
flow.Patient should have prompt measurement of blood glucose with the help of dextrostix .If 
hypoglycemia is documented or it is not possible to measure blood glucose a bolus of 2ml/kg 
of 25% dextrose solution, may be given intravenously. 
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CIRCULATION 
Within the first ½ hour of SE, blood pressure rises. Later, blood pressure either 
becomes normal or hypotensive. The circulatory shock which follows ongoing SE, severely 
deranges cerebral physiology. Hence it is necessary to monitor heart rate, peripheral 
perfusion and BP. Correct shock if identified with isotonic fluids. 
b)TERMINATION OF SEIZURE 
Rapid treatment of status epilepticus is crucial to prevent neurologic and systemic 
pathology. The goal of treatment always should be immediate diagnosis and termination of 
seizures. It is believed that early pharmacological intervention leads to termination of 
seizures with smaller doses than would be required if seizures were allowed to 
progress21. During status epilepticus there will be time-dependent loss of synaptic GABAA 
receptors and thus of GABA-mediated inhibition, which correlates with the progressive 
pharmacological resistance to GABAergic medication observed in refractory CSE.22 23  
BENZODIAZEPINES 
The benzodiazepines are some of the most effective drugs in the treatment of acute 
seizures and status epilepticus. The benzodiazepines most commonly used to treat status 
epilepticus are diazepam, lorazepam , and midazolam. All three compounds work by 
enhancing the inhibition of γ-aminobutyric acid (GABA) by binding to the benzodiazepine-
GABA and barbiturate-receptor complex. 
DIAZEPAM 
Diazepam is one of the drug of choice for first-line management of status epilepticus24 
25 Dosage:0.05-0.3mg/kg IV, at the rate of 0.1mg/kg/min Although the drug enters the brain 
rapidly because of its high lipid solubility, after 15 to 20 minutes it redistributes to other areas 
of the body, reducing its clinical effect26 27 Despite its fast distribution half-life, the 
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elimination half-life is approximately 24 hours. Thus, sedative effects potentially could 
accumulate with repeated administration. 
Diazepam in a typical intravenous dosage of 5 to 10 mg per minute terminates 
seizures of any type in about 75 percent of patients with status epilepticus28. Adverse effects 
include respiratory suppression, hypotension, sedation, and local tissue irritation. Diazepam 
also may be given rectally. 
Despite its pharmacokinetic and adverse effect limitations, diazepam remains an 
important tool in the management of status epilepticus because of its rapid and broad-
spectrum effect. 
LORAZEPAM 
Lorazepam has emerged as the preferred benzodiazepine for acute management of 
status epilepticus. Lorazepam differs from diazepam in two important respects. It is less lipid-
soluble than diazepam, with a distribution half-life of two to three hours versus 15 minutes 
for diazepam.Onset of action of lorazepam is 1-3 min. Therefore, it should have a longer 
duration of clinical effect. The anticonvulsant effects of lorazepam last 6 to 12 hours, and the 
typical dose ranges from 0.05mg/kg to 0.3mg/kg IV. This agent also has a broad spectrum of 
efficacy, terminating seizures in 75 to 80 percent of cases. Thus, lorazepam also is an 
effective choice for acute seizure management, with the added possibility of a longer duration 
of action than diazepam. 
MIDAZOLAM 
Midazolam has no advantage over diazepam or lorazepam.dosage:0.1-0.15mg/kg IV, 
with onset of action 1-5 min.It is extremely efficacious as an intra muscular anti convulsant 
when other routes are not available.So ideal for pre hospital therapy.It has rapid onset of 
action and controls seizures in 90% of patients.Its shorter half life and resultant increased risk 
of recurrence makes it a less preferred drug to lorazepam in the initial management of CSE. 
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A second dose of lorazepam or diazepam may be repeated in 5 - 10 min if seizures are not 
controlled with the first dose. 
PHENYTOIN 
Phenytoin is one of the most effective drugs for treating  status epilepticus, not 
responding to the initial 2 doses of benzodiazepines. It is given as 20mg/kg IV over 20 
min.Then if needed,10mg/kg iv infusion over 20 min.29 
The main advantage of phenytoin is the lack of a sedating effect. Side effects like 
arrhythmias and hypotension, local irritation, phlebitis, and dizziness may accompany 
intravenous administration. 
FOSPHENYTOIN 
Fosphenytoin is a water-soluble pro-drug of phenytoin that completely converts to 
phenytoin following parenteral administration within 8 to 15 minutes.30 31 It is metabolized 
by the liver and has a half-life of 14 hours. Because 1.5 mg of fosphenytoin is equivalent to 1 
mg of phenytoin.The initial dose of fosphenytoin is 15 to 20 mg PE per kg, so it can be 
infused at a rate as high as 150 mg PE per minute, a rate of infusion that is three times faster 
than that of intravenous phenytoin. Intramuscular doses also can be given, but the drug does 
not reach a therapeutic level for 30 minutes.32 
Adverse effects that are unique to fosphenytoin include perineal paresthesias and 
pruritus; however, both are related to higher rates of administration.33 Unlike phenytoin, 
fosphenytoin does not cause local irritation. Intravenous therapy has been associated with 
hypotension, so continuous cardiac and blood pressure monitoring are recommended.  
Intravenous pyridoxine 100 mg should be administered to all children below two years with 
cryptogenic CSE, not responded to phenytoin infusion. Diagnosis of pyridoxine-dependent 
seizures is not to be missed.34, Apnea is a complication during administration. 
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PHENOBARBITAL 
Phenobarbital typically is used after a benzodiazepine or phenytoin has failed to 
control status epilepticus. The normal loading dose is 15 to 20 mg per kg over 30 minutes. 
Because high-dose phenobarbital is sedating, airway protection is an important consideration, 
and aspiration is a major concern. Intravenous phenobarbital also is associated with systemic 
hypotension. 
MANAGEMENT OF REFRACTORY STATUS EPILEPTICUS 
Seizures not controlled with adequate doses of benzodiazepines,phenytoin or 
phenobarbitone has been defined as refractory SE. 
Midazolam appears to be a good choice for initial treatment of RSE in children. 
Midazolam is given as 0.15mg/kg IV bolus,followed by a continuous infusion of 1μg/kg/min 
with increments of 1μg/kg/min every 15 minutes until the seizure is controlled. The 
maximum rate of infusion is 15-20 μg/kg/min.The drug has anxiolytic, muscle relaxant, 
hypnotic and anti convulsant effects. 
Status epilepticus not responding to midazolam, may be treated with sodium 
valproate,15-20mg/kg bolus (max 40mg/kg), followed by an infusion of 5mg/kg/hr. The 
advantages of this drug are that it has less sedation than other drugs, good cardiovascular 
profile and enables quick recovery. 
A loading dose of thiopentone sodium 3-5mg/kg followed by an infusion has also 
been given for refractory status epilepticus. But severe hypotension requiring vasopressor 
therapy and prolonged post-infusion weakness delaying weaning make it a less commonly 
used drug in RSE. 
Propofol has also been used in refractory status epilepticus in children. Loading 
dose:1-3 mg/kg and infusion:2-10mg/kg. Apnea, bradycardia, hypotension are some of the 
common adverse effects. However recovery is quick after cessation of therapy. During 
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administration of the drugs mentioned for RSE, EEG monitoring is mandatory in the 
intensive care unit. 
 c) IDENTIFICATION AND TREATMENT OF CAUSAL OR PRECIPITATING 
FACTORS 
Management of CSE includes identification and treatment of the underlying cause. In 
the absence of an obvious aetiology, blood glucose, blood gases and electrolytes (including 
sodium, calcium and magnesium) should be tested and any metabolic derangement should be 
corrected. However, the diagnostic assessment should not delay treatment and clinicians 
should be able to diagnose CSE on clinical grounds alone. In general, an EEG, neuroimaging 
or other laboratory studies are not needed before the initiation of anticonvulsant therapy. If 
available, indications for emergency EEG include:35 
• Clinical impression of pseudoseizures presenting as CSE. 
• Unexplained altered awareness or no improvement or return to baseline of mental 
status after controlling overt convulsive movements (to exclude ongoing seizure 
electroencephalographic activity). 
• Neuromuscular paralysis. 
• High-dose suppressive therapy for refractory CSE. 
OUTCOME 
            Outcome is determined by, etiology, age, duration, treatment. Ultimately mortality 
related to, damage to the CNS caused by the acute insult precipitating SE, systemic stress 
from SE(major cause because of anoxia, acidosis, shock), injury from repetitive epileptic 
discharges within the CNS. Mortality increases from 3% to 32% if the duration of seizures 
becomes more than 1 hour. 
Neurologically normal children and children with febrile status have a favourable 
prognosis. Improved outcome is a result of timely and approximate evaluation and treatment. 
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Most favourable for patient who respond to first line agents, but obviously the underlying 
cause of status, determine the outcome. Cognitive function may be impaired (particularly 
memory) in patients with prolonged SE and is more common when significant 
hypoxemia(aspiration) intervened. Outcome may be worse when SE is managed 
inappropriately. Most common mistakes seen are, inadequate dosing, Failure to order 
maintenance therapy. Failure to do the latter results in recurrence. AED should be continued 
particularly if a structural lesion resulted in SE. 
Gulati S,et al36,Department of Pediatrics, AIIMS, New Delhi, India, done a retrospective 
study on the clinical profile, immediate outcome and possible risk factors of SE in pediatric age group 
admitted to PICU in a tertiary care center.Case records of 451 neuroemergency patients admitted 
between January 1993 to April 2000 analysed, out of which 30 patients had status epilepticus. The age 
group varied from 1 to 120 months with mean of 56.6+/- 46.5 months. Seventeen patients were less 
than 60 months. Sixteen patients (53.3%) presented with SE as first presentation without prior history 
of seizure activity. Nine patients died (30%) during hospital course. Seizure duration> 45 minutes (p-
0.001) and presence of septic shock (p-0.001) were associated with significantly more mortality. This 
study conclude that there is a need to abort seizure activity at the earliest and this improves immediate 
outcome. 
In an Indian study done by Singhi S, Murthy A et al.37, at Chandigarh, they 
compared the efficacy of continuous midazolam versus diazepam infusion in RSE. It was an 
open-label, randomized control study at their Intensive Care Unit. The subjects included 40 
children, 2 to 12 years of age with refractory status epilepticus. They found that the median 
time to control seizures was 16 minutes in both the groups, but in the midazolam group, 
seizures recurred in more children (57% versus 16% in diazepam group; p<0.05).  About half 
of the patients needed mechanical ventilation and 40% had hypotension in both groups but 
they found that the mortality was higher in the midazolam group ( 38%) as compared to the 
diazepam group ( 10.5 %, p< 0.01>0.05). They concluded that continuous midazolam and 
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diazepam infusions were equally effective for control of RSE. However, midazolam was 
associated with more seizure recurrence and higher mortality in RSE predominantly caused 
by central nervous system infections. 
Rod C Scott et al,38 Institute of Child Health, London,justified separate analysis in 
children as It differs from adult CSE in aspects of epidemiology, pathophysiology and 
clinical presentations. This study conclude that Febrile and acute symptomatic CSE are most 
common in children aged <2 years, whereas cryptogenic-idiopathic and remote symptomatic 
aetiologies are more common in older children. Mortality is 3-5% and morbidity directly 
attributable to CSE is less than 15%. Aetiology is the main determinant of outcome, while the 
separate effect on outcome of duration, age and treatment remains controversial. The risk of 
sequelae in unprovoked and febrile CSE is low.Prehospital administration of benzodiazepines 
is safe and simplifies subsequent management of CSE in the hospital setting. Treatment 
includes resuscitation measures, identification and treatment of causal factors and early 
antiepileptic treatment following local guidelines that may be based on national guidelines. 
Sachin Admuthe,et al,39 Retrospective study of clinical profile of Status Epilepticus 
in children.Institute of Child Health & Research Centre, Bijapur. from Jan 2004 to Dec2004, 
27 patients who presented with status epilepticus. Their age group ranged from 4 months to 
13 years with a mean of 4.5, 3.69 years. Boys and girls were almost in equal proportion 
(15:12). 10 patients (37.04%) with status epilepticus had previous history of seizure activity. 
The remaining 17 (62.96%) presented with status epilepticus as the first. Generalized Status 
Epilepticus is the most common type. The majority of children presented with Status 
Epilepticus at the first presentation are without a prior history of seizure activity.Most 
children with Status Epilepticus respond to combination of Midazolam and Phenytoin. 
In a small retrospective study comprising of seven patients with refractory status 
epilepticus done by Kumar A, Bleck TP 40, they found that midazolam infusions terminated 
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status epilepticus in all patients in less than 100 seconds as determined by clinical observation 
( three patients) or electroencephalographic monitory ( four patients). But all the patients 
received mechanical ventilation before receiving midazolam. They found that one patient 
developed mild hypotension. In this small study, they concluded that midazolam appears to 
be an effective and safe alternative to high dose barbiturate coma for the termination of status 
epilepticus when conventional agents have failed. 
Eriksson KJ, Koivikko MJ.41Tampere University Hospital, Finland done  
retrospective study includes 65 children treated for status epilepticus . Aetiology of the 
condition, effectiveness of the treatment protocol, including short barbiturate anaesthesia to 
prevent prolonged status epilepticus episodes, and neurological outcome were 
evaluated.There were no status epilepticus-related deaths. The cut-off point of status 
epilepticus duration for significant risk for permanent neurological sequelae was 2 hours. 
Treatment protocol, including short barbiturate anaesthesia in refractory cases, was able to 
abort status epilepticus in less than 2 hours in 75% of cases. This study conclude that early 
and prompt use of barbiturate anaesthesia should be encouraged, and may explain our low 
morbidity figures.  
 B G R Neville, R F M Chin, R C Scott42 . Febrile CSE is the commonest single 
group with a good prognosis in sharp distinction to CSE related to central nervous system 
infections which have a high mortality. The aim of treatment is to intervene at 5 min and 
studies indicate that intravenous (i.v.) lorazepam may be a better first-line treatment than 
rectal diazepam and i.v. phenytoin a better second-line treatment than rectal paraldehyde. An 
epidemiological study strongly supports the development of prehospital treatment with buccal 
midazolam becoming a widely used but unlicensed option in the community. More than two 
doses of benzodiazepines increase the rate of respiratory depression without obvious benefit. 
The 1 year recurrence rate is 17% and the hospital mortality is about 3%. 
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  Nicholas S Abend, Dennis J Dlugos43 in their study aimed to describe nonconvulsive 
status epilepticus in terms of patient age, etiology, initial presentation, and 
electroencephalogram and neuroimaging findings. Twenty children with nonconvulsive status 
epilepticus were identified by a retrospective review of children who underwent long-term 
electroencephalogram monitoring in a pediatric intensive care unit. Age ranged from 2 
months to 18 years, and in Nonconvulsive status epilepticus occurs in a heterogeneous group 
of children, results from acute symptomatic etiologies in children aged <1 year, most 
frequently follows isolated convulsions but can occur with only preceding mental status 
change, and is often prolonged. These findings suggest that a high level of suspicion for 
nonconvulsive status epilepticus must be maintained, and long-term electroencephalogram 
monitoring may be indicated in a large number of patients. 
Gulser Esen Besli et al turkey.44study to evaluate the etiology, clinical profile, and 
short-term outcome of status epilepticus cases .Study group: 56 cases of SE who ages 
between 3 months and 15 years. Observed clinical course and outcome of 53 cases for 6 to 18 
months. Results: While the most common cause of status epilepticus in children younger than 
2 years is febrile, idiopathic/cryptogenic and remote symptomatic are in children older than 2 
years. The rate of recurrence of seizure was significantly higher in cases with existing 
neurological abnormalities, prior epilepsy and seizures with remote symptomatic etiology. 
The most common triggering factors of SE development in cases with epilepsy were 
noncompliance for antiepileptic drugs and infectious fever. Conclusions: The risk factors of 
seizure recurrence were the presence of prior epilepsy, existence of neurological 
abnormalities and remote symptomatic etiology. Improving the compliance of patients and 
their families to take medicine appropriately and training them how to cope with febrile 
illnesses may decrease the recurrence of seizures.  
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Eriksson.K, et al,45contributing to the duration of a single convulsive seizure >5 
minutes were analyzed in 157 children. The medically treated episodes were compared with 
seizure episodes resolving without treatment (n = 27). Major differences were in age (p = 
0.016) and etiology (p = 0.003), and the association between treatment delay and response 
became significant after 30 minutes when this was analyzed as a single variable (p = 0.003) 
in Cox regression analysis. 
 DC Hesdorffer, G et al,46 Mailman School of Public Health, Columbia University. 
studyTo determine the risk of recurrence of status epilepticus (SE) in a population-based 
sample and to identify risk factors for recurrence.All first episodes of afebrile SE  between 
January 1, 1965, and December 31, 1984 included. Among the 183 episodes of first afebrile 
SE, the risk of recurrent SE was 31.7% over a 10-year follow-up period. The risk of 
recurrence was about 25% for those with acute symptomatic SE, remote symptomatic SE, 
and idiopathic cryptogenic SE. Recurrence was 100% for those with progressive symptomatic 
SE. Female gender and progressive symptomatic etiology increased the risk for recurrent SE. 
Study shows that Status epilepticus (SE) recurs in about one-third of individuals with a first 
episode of SE. Except for SE occurring in the setting a progressive brain disorder, the risk of 
recurrence is about 25%, regardless of the underlying etiology. Female gender and lack of 
response to the first antiepileptic drug medication are at greatest risk for recurrence. 
 R K Singh S  et al47 Washington, DC. Prospectively study a total of 1,382 patients 
presented with new-onset seizures between 2001 and 2007 to characterize children with new-
onset seizures presenting as status epilepticus at a tertiary care children's hospital. The 
average age was 3.4 years. The majority of seizures (72%) lasted between 21 and 60 minutes, 
had no significant past medical history; one-fourth had a family history of epilepsy. 
Combined CT and MRI provided a diagnosis in 30%. CT was helpful in identifying acute 
vascular lesions and acute edema, whereas MRI was superior in identifying subtle 
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abnormalities and remote symptomatic etiologies such as dysplasia and mesial temporal 
sclerosis.Conclude that Children who present in status epilepticus that is not a prolonged 
febrile convulsion should undergo neuroimaging in the initial evaluation. For any child who 
presents in status epilepticus and has not yet returned to baseline, the possibility of 
nonconvulsive status epilepticus should be considered. Although CT is often more widely 
accepted, especially in the urgent setting, strong consideration for MRI should be given when 
available, due to the superior yield.  
Lacroix J, et al.48Canada.Retrospective study to characterize the etiology, course, 
and prognosis in children admitted to a pediatric intensive care unit (ICU) for status 
epilepticus. One hundred forty-seven children. Status epilepticus was caused most often by 
epilepsy (n = 52), atypical febrile convulsions (n = 21), bacterial meningitis (n = 20), 
encephalitis (n = 20), intoxication (n = 8), or a metabolic disorder (n = 12). A normal 
neurologic status before status epilepticus and age < 4 yrs seem to be markers of good 
prognosis, while encephalitis and meningitis appear to be markers for morbidity and 
mortality. This study shows that most cases of status epilepticus were caused by epilepsy, 
atypical febrile seizure, encephalitis, meningitis, or metabolic disease. The mortality rate 
during the ICU stay was 6%. The prognosis was good in most surviving cases, more so if the 
neurologic development of the child was normal before the status epileptic. 
Tirupathi S, et al49.ireland Study is to identify clinical features and therapeutic 
decisions that influence admission, children presenting with CSE. In this study  evaluated 47 
cases over a three year period (2003-2006). Median age at presentation in the ICU group was 
17 months (range 3 months-11 years) compared to 46 months in the ward group (range 3 
months-10 years). Fifty per cent of patients in both groups had a previous history of seizures. 
Median duration of pre-hospital seizure activity was 30 min in both groups. ward. Febrile 
seizures were the most common aetiology in both groups.In this they conclude that younger 
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age at presentation, administration of more than two doses of benzodiazepines and deviation 
from the CSE protocol appear to be factors which influence admission of children to ICU. 
Recognition of pre-hospital administration of benzodiazepines and adherence to therapeutic 
guidelines may reduce the need for ventilatory support in this group. 
. Alldredge BK et al,50 This study showed that prehospital diazepam therapy was 
associated with SE of shorter duration (32 min vs 60 min; P = .007) and a reduced likelihood 
of recurrent seizures in the emergency department (58% vs 85%; P = .045). There were no 
significant differences between rectal and intravenous diazepam therapy with regard to SE 
duration, intubation, or recurrent seizures in the emergency department. These data suggest 
that prehospital administration of diazepam may shorten the duration of SE in children and 
simplify the subsequent management of these patients in the emergency department. 
Towne AR, et al51. Determinants of mortality in status epilepticus. Epilepsia. 1994 
Jan-Feb;35(1):27-34. 
Using univariate and multivariate regression analysis ,they studied seizure duration, 
seizure type, age, etiologies, other clinical features, and mortality among 253 adults with 
status epilepticus (SE) admitted to the Medical College of Virginia. Cerebral vascular disease 
and discontinuation of antiepileptic drugs (AEDs) were the most prominent causes of SE, 
each accounting for approximately 22% of all patients in the series. The other principle 
etiologies were alcohol withdrawal, idiopathic, anoxia, metabolic disorders, hemorrhage, 
infection, tumor, drug overdose, and trauma. When the patients were divided into two groups, 
the group with SE lasting < 1 h had a lower mortality as compared with seizure duration > or 
= 1 h. Low mortality rates were noted in alcohol and AED discontinuation etiologies. Anoxia 
and increasing age were significantly correlated with higher mortality. The mortality rates of 
partial and generalized SE were not significantly different. Race and sex did not affect 
mortality significantly. Our findings represent the first multivariate analysis of predictive 
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indicators of mortality in SE and demonstrate that specific factors influence mortality rate in 
SE. 
Stefan Beyenburg, et al,52 study concludes that Although prospective studies are still 
lacking, NCSE may be one of the most frequently missed diagnoses in patients presenting 
with altered mental status. Elderly patients are at particular risk of diagnostic errors because 
of the broad range of presentations of NCSE, significant comorbidities (especially 
cerebrovascular disease), limited awareness of this particular seizure emergency or 
difficulties with access to electroencephalography. Although diagnostic criteria and treatment 
remain controversial, the diagnosis of NCSE is important because it is potentially reversible. 
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AIM AND OBJECTIVE 
 
Aim of the study is to determine immediate outcome of status epilepticus in children 
in our hospital. 
Secondary aim is to identify the risk factors influencing the outcome of status 
epilepticus 
 
 
 
 
 
 
  
28 
 
MATERIALS AND METHODOLOGY 
 
STUDY DESIGN              :  Descriptive study 
STUDY PERIOD                  :  October 2009 to october 2010 
STUDY POPULATION :  Children from 1 month to12 yrs of age, who                                                    
      have been managed as SE                                                 
STUDY PLACE                   :  Dept of Pediatrics, TVMC       
INCLUSION CRITERIA       :  All children presented with SE (including non convulsive SE  
and secondary  generalized), managed with anti convulsant      
as per protocol in the  above age group in E.R.            
EXCLUSION CRITERIA      :  seizures controlled before arrival to the hospital or before                   
    starting IV therapy. 
   Simple partial SE and  myoclonic SE, with normal vital signs   
   and without loss of consciousness  Seizures occurred during   
   hospital stay, not at arrival. 
SAMPLE SIZE:    All cases presented with status epilepticus in our pediatric casuality during 
the study period. 
SAMPLING TECHNIQUE: All cases included over that period.  
DROP OUTS: Totally 92 cases were included. Five cases absconded during hospitalisation. 
SE: Defined as seizure lasting more than 30 min of a) continuous seizures or b) two or 
discrete seizures between which there is incomplete recovery of consciousness. 
CSE: Refers to GTCS either primary or secondary to focal onset, in which whole or part of 
the body muscles having visible convulsions. 
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NCSE: refers to persistent seizure activity but no visible convulsions. Here they may have 
subtle signs of seizure activity such as unresponsiveness/ALOC or acute confusion state, 
apnea, defective DEM ,deviation of eyes, nystagmus. 
NEURO EMD (ELECTRICAL SEIZURES): No visible sign of seizure activity, but EEG 
shows ongoing seizure activity. Example ; SE in patients paralysed with neuromuscular 
blockade. 
INITIAL SEIZURE CONTROL; Seizure control by drugs at the time of first contact with the 
Emergency room. 
CLINICAL CONTROL: No evidence of seizure activity such as convulsions, apnea, 
unresponsiveness, defective DEM, conjugate deviation of eyes, nystagmus, twitching of 
eyelids, lip smacking movements ,dilated pupils, tachycardia, excessive secretions, 
hypertension, airway stable with intact protective reflexes, stable respiration, DEM present 
,with or without regaining consciousness. 
GOOD RESPONSE: Defined as seizure activity controlled with AED within 60 minutes of 
contact with hospital and initiation of therapy .That is controlled with first line drugs. 
REFRACTORY SE: RSE is defined as seizures that are not controlled with adequate doses of 
BZD, Phenytoin, phenobarbitone, and or seizure lasting more than 1 hour. 
MORTALITY: Defined as death occurring in hospital during the course of treatment of SE 
without improvement and regaining baseline consciousness.  
AMA : Means, discharged against medical advice during the treatment of status epilepticus 
without improvement and regaining baseline consciousness. 
DURATION: Time starting from the onset of an episode of seizure prior till reaching the 
hospital or starting from the onset of first episode of seizure if having more than one episode 
of seizure with impaired level of consciousness. 
30 
 
HISTORY OF EPILEPSY: Defined as two or more unprovoked seizures in the past whether 
on treatment or not. 
FEBRILE CSE: Status epilepticus occurring when the only provocation is a febrile illness, 
after excluding a direct CNS infection 
MANOEUVRE:  
92  children between the age group of 1 month to 12 years admitted in our hospital 
with the diagnosis of status epilepticus were included in the study group. Institutional consent 
and parental consent were obtained. First the cases were selected as per the inclusion criteria. 
Each child had been assessed on arrival and a preliminary history was obtained and 
documented in a preformed profoma. Rapid cardio pulmonary assessment was made, Spo2 on 
arrival, BP, presence of shock, pupil, were monitored. Before starting IV therapy, blood 
sample was taken for baseline investigations (sugar, calcium, and electrolytes).Then the cases 
were managed according to the protocol followed in our ER and admitted in wards/PICU. 
Detailed history were obtained including duration of seizure, distance from the place 
where the fits occurred, mode of transport, prehospital therapy, precipitating factors, prior 
seizures/SE, drug history and compliance development milestone, prior neurological status. 
Complete clinical examination was made including neurological examination. Relevant 
investigation were done like CSF analysis CT brain /USG cranium, EEG, etc. during course 
of illness and therapy were monitored regularly till discharge. Computed tomography of brain 
was done in all patients with new onset of seizure and focal seizure. Magnetic resonant 
imaging of brain was done in selected cases.  
Final diagnosis of various underlying problems was made based on the clinical 
history, physical examination and various investigation. The patients were further followed 
up for any complications acquired during hospital stay, duration of ventilation required length 
of stay in hospital stay. The neurological status of the child at the time of discharge was 
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noted. Time taken for control of refractory SE, time taken for full recovery of consciousness, 
requirement for prolonged ventilator support ,refractory shock or subsequent shock following 
midazolam or due to complication like sepsis, maximum dose and duration of ionotropes and 
midazolam infusions, recurrent of fits, complication  were noted. They were followed for one 
month. Then the neurological status at the end of one month was reassessed. Their 
neurological status was compared with the previous neurological status. 
Outcome was determined by the following variables. Complete recovery with no 
neurological sequel, and neurological sequele Death, AMA, Observations were entered as 
tables and percentage charts. According to the final outcome the children were divided into 
two groups. Death were taken as poor outcome group and those children recovered 
completely with or without any new neurological sequel were taken as good outcome. 
Predictors of poor outcome were analyzed for the following risk factors compared with good 
outcome groups and considered statistically significant if p value is <0.05.  
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1.5.DURATION OF TRANSPORT 
Distance travelled No of cases Percentage 
<5 km 16 17.4 
5-10 km 22 23.9 
10-20 km 16 17.4 
20-40 km 25 27.2 
>40 km 13 14.1 
Total  92 100 
Mean:  19.15 Km                  
Range:  0.5-60 Km              
S.D:    16.2697 
 
Of the 92 children 16 cases17.4% of the children with status epilepticus reached 
TVMCH in less than 5km; 22cases from5-10 km; 16 cases from 10-20 km; 25cases from 20-
40 km and 13 cases from more than 40 km. Mean duration being 19 km. Minimum duration 
travelled was 0.5km and maximum duration was 60 km.   
 
1.6. DURATION OF SEIZURE AT THE TIME OF ARRIVAL 
Duration of seizure in min No of cases n=92 Percentage 
30-60 min 75 81.5% 
>60 min 17 18.5% 
Mean : 78.12 min 
Range: 30 min-10 hrs 
SD :    104.938 
 
81.5% (75) of the cases reached ER within 30-60 mins duration of seizure and 18.5 % 
(17) reached with seizure more than 60 min. Mean duration of seizure was 78.12 minutes. 
Minimum duration was 30 mins and maximum duration was 10 hrs. 
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1.8. SEIZURE EPISODE  
28 cases 35% presented with first episode of seizure and 64 cases 65% with previous 
history of seizure. 
Seizure episode No of cases(n=92) Percentage 
First episode of seizure 28 35.0% 
Previous episode of seizure 64 65.0% 
 
 
SEIZURE EPISODE 
 
 
 
 
 
28
64
first episode previous history of seizure
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1.9. FEBRILE OR AFEBRILE SEIZURE 
H/O FEVER  No of cases Percentage 
Febrile 65 70.7 
Afebrile 27 29.3 
Total 92 100 
 
From above table 70.7% (65) cases presented with fever and 29.3% (27) cases were 
afebrile. 
 
1.10.CO MORBID FACTORS 
SI NO Complications No of cases 
(n=92) 
1 Intubation on arrival 9 (9.8%) 
2 Decompensated shock 8(8.7%) 
3 Hypoglycaemia  9((9.8%) 
4 Hypocalcaemia 5(5.4%) 
5 Acidosis 18 (19.6%) 
6 Raised ICT 8(8.7%) 
 
In children presenting with SE at the time of arrival, the most common Co morbid 
factor is acidosis in 18 cases (19.6%).  
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1.12. REFRACTORY SEIZURE 
In this study 15% (14 out of 92) had refractory SE. In the 7 cases survived with RSE, 
seizure controlled with minimum of midazolam infusion 1μgm/Kg/min to maximum of 
4μgm/Kg/min.  
1.13 ETIOLOGY 
SI NO Final diagnosis No of cases(n=92) Percentage 
1 Febrile seizure 17 18.5 
2 Acute CNS infection 18 19.6 
3 Remote causes 25 27.2 
4 Idiopathic SD 15 16.3 
5 Neurocutaneous syndrome 02 2.2 
6 IE metabolism 02 2.2 
7 Non compliance 05 5.4 
8 CNS haemorrhage 02 2.2 
9 Systemic illness 03 3.3 
10 Tumour 03 3.3 
 
From the above table, the most common etiology associated with status epilepticus in 
92 children was remote causes 27.2% (25 cases), next being acute CNS infection 19.6% (18 
cases), febrile seizure 18.5% (17 cases) and cryptogenic/idiopathic SD 16.3% (15 cases). 
 
CSF Analysis : CSF analysis was done for 21 children, 6 cases had normal CSF finding.15 
cases had abnormal values.  
CT brain :  done for 44 cases.30 cases had abnormal findings.MRI done for 9 cases,all 
showed abnormal findings.   
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2. ANALYSIS OF OUTCOME 
Out of 92 cases, 5 went on AMA and didn’t complete the study to know the outcome. So 
the outcome of remaining 87 cases are analysed here.  
2.1 AGE AND OUTCOME 
Age Recovered Death Total 
<1yr 19 (86.4%) 3 (13.6%) 22 (100%) 
1-5yrs 27 (87.1%) 4 (12.9%) 31 (100 %) 
6-10yrs 25 (83.3%) 5 (16.7%) 30 (100%) 
>10yrs 3 (75.0%) 1 (25.0%) 4 (100%) 
Total 74 (85.1%) 13 (14.9%) 87 (100%) 
           Chi2: 0.519 df: 3    p- Value: 0.915 
The above table explains the outcome across the various age groups. Of the total 87 
patients 74 (85.1%) have recovered and 13 (14.9%) have died. Almost the same proportion is 
maintained across the all age groups. So the age is not having significant association with the 
outcome (p- Value > 0.05). 
2.2. DURATION OF TRAVEL AND OUTCOME 
Distance KM Recovered Death Total 
<5 15( 93.8%) 1(6.3 %) 16( 100%) 
5-10 18( 100%) 0(0 %) 18(100 %) 
11-20 13(81.3 %) 3(18.8 %) 16(100 %) 
21-40 22( 88%) 3( 12%) 25(100 %) 
>40   6  (50 %) 6 (50%) 12(100 %) 
Total 74(85.1 %) 13(14.9 %) 87(100%) 
Chi2: 16.070   df: 4    p- Value: 0.003 
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The above table explains the relationship between distance of travel and the outcome.  
Outcome is good among cases travelled less than 10 km and mortality is very low among 
children travelled less than 10 km. Mortality is very high among 12 children travelled more 
than 40 km. Out of 12 cases, 6 cases (50%) recovered and 6 cases (50%) died. It shows that 
lower the distance better the outcome and higher the distance higher the bad outcome (death). 
The association is also statistically significant (p –Value < 0.05). 
2.3. PREHOSPITAL THERAPY 
Prehospital therapy Recovered Death Percentage 
Yes 17 (73.9 %) 6 (26.1 %) 64 (100%) 
No  57 (89.1%) 7 (10.9 %) 23 (100%) 
Total  74 (85.1%) 13 (14.9%) 87 (100%) 
Chi2: 3.055  df: 1    p- Value: 0.08 
The above table shows that the cases had prehospital therapy had poor outcome 
(26.1%) than the case who didn’t receive prehospital therapy (7%). But this difference is not 
statistically significant (p- value > 0.05).  
2.4. DURATION OF SEIZURE BEFORE ARRIVAL 
Duration of seizure 
       Minutes 
Recovered Death Total  
30-60 66(93.0%) 5(7.0 %) 71(100%) 
>60 8(50.0 %) 8(50.0 %) 16(100%) 
Total 74(85.1 %) 13(14.9 %) 87( 100%) 
Chi2: 18.959  df: 1    p- Value: 0.000 
The above table shows that prolonged duration of the seizure before arrival to ER had 
poor outcome. This is also statistically significant (p- value <0.05). 
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2.5 SEIZURE TYPE AND OUTCOME 
Chi2: 7.151   df: 3    p- Value: 0.067 
 
Among the seizure type death occurred in children with GTCS and NCSE. Out of 74 
cases with GTCS 10 cases died and in NCSE 3 cases(50%) died out of 6 cases(100%).This is 
statistically not significant. (p- Value:>0.05). 
 
2.6. FEVER ASSOCIATION AND OUTCOME 
Fever H/O Recovered Death Total 
Febrile  54 (84.4%) 10 (15.6%) 64 (100%) 
Afebrile  20 (87%)  3 (13%) 23 (100%) 
Total 74 (85.1%) 13 (14.9%) 87 (100%) 
Chi2: .089   df: 1    p- Value: 0.766 
 
From the above table all the proportions of outcome are maintained almost equally in 
both the febrile and afebrile group. The difference is not statistically significant (p value > 
0.05). 
 
 
 
 
Fit Type Recovered Death Total 
GTCS 64(86.5%) 10(13.5%) 74(100%) 
NCSE 3(50%) 3(50%) 6(100%) 
FOCAL 0(0%) 5(100%) 5(100%) 
FOCAL-S 0(0%) 2(100%) 2(100%) 
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2.7. NEUROLOGICAL STATUS 
Neurological status Recovered  Death Total 
Normal  48 (90.6%) 5(9.4%) 53(100%) 
Abnormal  26(76.5%) 8(23.5%) 34(100%) 
Total  74(85.1%) 13(14.9%) 87(100%) 
Chi2: 3.238   df: 1    p- Value: 0.072 
Among the previously neurological abnormal children of 34 cases, 23.5% (8) cases 
had poor outcome. Only 9.4% (5) of the neurologically normal children (n=53) had poor 
outcome. But this different is not statistically significant (p- value >0.05). 
 
2.8. COMORBID FACTORS 
SI NO Risk factors Recovered 
(n=74)  
Death 
(n=13)  
Total  
(n=87) 
p value
1 Shock  6(8.11%) 2(15.38%) 8(9.2%) 0.000 
2 Fever 54(72.97%) 10(76.92%) 64(73.56%) 0.766 
3 Raised ICT  6 (8.10%) 0 (0%) 6(6.897%) 0.287 
4 Intubation  11(14.86%) 8(69.54%) 19(21.84%) 0.000 
5 SaO2 on arrival(low) 30(40.54%) 9(69.23%) 39(44.83%) 0.004 
6 Hypoglycemia  5(6.76%) 4(30.76%) 9(10.34%) 0.015 
7 Hypocalcemia   8(10.81%) 8(69.54%) 16(18.39%) 1.000 
8 Acidosis  8(10.81%) 8(69.54%) 16(18.39%) 0.000 
9 Delay in regain consciousness
after seizure 
22(29.73%) 2(15.38%) 24(27.58%) 0.942 
 
From the above table the risk factors significantly affecting the outcome are hypoxia 
at the time of arrival, decompensated shock, respiratory failure requiring intubation, 
hypoglycemia and acidosis. (p- value <0.05). 
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2.9 AED TREATMENT RESPONSE AND OUTCOME 
AED Treated Recovered Death Total 
Diazepam 1 14(93.3%) 1(6.7%) 15(100%) 
Diazepam 2 22(95.7%) 1(4.3%) 23(100%) 
Phenytoin 1 18(85.7%) 3(14.3%) 21(100%) 
Phenytoin 2 7(100%) 0(0%) 7(100%) 
Phenobarbitone 6(66.7%) 3(33.3%) 9(100%) 
Midazolam 1μgm/Kg/min 4(80%) 1(20%) 5(100%) 
Midazolam 2μgm/Kg/min 1(100%) 0(0%) 1(100%) 
Midazolam 3μgm/Kg/min 0(0%) 1(100%) 1(100%) 
Midazolam 4μgm/Kg/min 2(40%) 3(60%) 5(100%) 
Total 74(85.1%) 13(14.9%) 87(100%) 
Chi2: 20.427   df: 8    p- Value: 0.009 
 
From the above table if the seizure control is poor with initial first line AED, 
mortality is very high.In children receiving Midazolam infusion (3-4μgm/Kg/min) had poor 
outcome.This is also statistically significant p- Value < 0.05. 
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2.10. ETIOLOGY AND OUTCOME  
SI NO Final diagnosis           Recovered Death  Total Percentage 
1 Febrile seizure 17 (100%) 0(0%) 17(100%) 
2 Acute CNS infection 13(76.5%) 4(23.5%) 17(100%) 
3 Remote causes 19(76%) 6(24%) 25(100%) 
4 Idiopathic SD 12(92.3%) 1(7.7%) 13(100%) 
5 Neurocutaneous 
syndrome 
02(100%) 0(0%) 2(100%) 
6 IE metabolism 01(50%) 01(50%) 2(100%) 
7 Non compliance 04(80%) 01(20%) 5(100%) 
8 CNS haemorrhage 02(100%) 0(0%) 2(100%) 
9 Systemic illness 03(100%) 0(0%) 3(100%) 
10 Tumour 01(100%) 0(0%) 1(100%) 
TOTAL  74(85.1%) 13(14.9%) 87(100%) 
 
In this study 87 children out of 92 cases who completed the study, 74 cases recovered 
and 13 cases died due to varied etiology. All the febrile seizure cases presented as SE had 
good outcome. Acute CNS infection, remote causes, non compliance of AED, IEM, are the 
etiological factors influence the poor outcome. 
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2.11. RECOVERED WITH SEQUELE AND OUTCOME 
SI. No Etiology Total cases Recovered with sequele 
1 Acute CNS infection 18 2 (11.11%) 
2 CNS haemorrhage 2 1 (50%) 
3 Idiopathic SD 15 1 (6.66%) 
4 Remote cause 25 1 (4.0%) 
Total 5 cases 
 
Among 87 cases, 5 cases developed neurological sequele. The most common 
etiological agents associated with sequele are acute CNS infection, CNS haemorrhage, 
Idiopathic SD, remote cause. 
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DISCUSSION 
 
In this study there were total of 92 cases of status epilepticus within the study period. 
The mean  age of  the patient in the present study was 4.9yrs.The youngest age being 2 month 
and the eldest being 11 years. Children < 1year account for 22 cases 23.9 % of the total cases 
(n=92) and 54 cases 58.6 % out of the total cases were children < 5 years. Almost 60% of 
them were in the group < 5 years. No of cases >10yrs was only 6.5%, 6 cases. Out of 92 
children, male children were 46 (50%) and female children were 46 (50%). Sachin 
Admuthe, et al,53 in his study showed mean age was 4.5yrs and weak evidence of difference 
of sex.  
 
 
 
 
 
 
Out of 92 cases, 20 cases (21.7 %) were referred from GH. 5 Cases (5.4 %) from PHC 
and 14 cases (15.2%) were referred from private hospital. 53 Cases (57.6%) reached our 
hospital    without any treatment or referral. Of the 92 children, 16 cases17.4% of the children 
with status epilepticus reached TVMCH in less than 5km; 22 cases from 5-10 km; 16 cases 
from 10-20 km; 25cases from 20-40 km and 13 cases from more than 40 km. Mean duration 
being 19 km. Minimum duration travelled was 0.5 km and maximum duration was 60 km.   
   Prehospital therapy with AED given to 24 patients (26.1%), remaining  68 (73.9%)  
didn’t receive any prehospital therapy with AED, though some of them had been referred. 
Out of 23 children who had received prehospital therapy only 16 had proper prehospital 
therapy.7 children had received improper medication or drug dosage.  16 chilldren received 
Study  Mean age 
Sachin Admuthe et al 4.5yrs 
Maytal J et al 54 5 yrs 
R K Sing's et al55 3.4yrs 
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injection diazepam, 6 children received upto phenytoin and 1 children received 
phenobarbitone as Prehospital therapy AED.  
81.5 % (75) of the cases reached ER within 30-60 min and 18.5 % (17) reached with 
seizure more than 60 min. Mean duration of seizure was 78.12 minutes. Minimum duration of 
seizure was 30mins and maximum duration was 10 hrs. K. Eriksson et al,45 study concluded 
that the association between treatment delay and response became significant after 30 
minutes when this was analyzed as a single variable (p = 0.003) 
CSE accounts about 93.5% of the total seizure during arrival. The commonest among 
them was GTCS - 77 (83.7%). Focal seizure accounts about 8 % (7 cases). Out of which 2 
cases presented with secondary generalisation. Two cases (2.2%) were multifocal. Six cases 
(7 %) were NCSE, of which 4 cases were of initial GTCS and 2 cases were of initial focal 
seizure. 
28 cases 35% presented with first episode of seizure and n=51 65% with previous 
history of seizure. Out of 92 cases, 70.7% (65) cases presented with fever and 29.3% (27) 
cases were afebrile. Garzon et al56 study showed 40.6% with no prior history of seizure.43% 
in Mah JK et al,57 Kalra veena et al 58study showed53.3% with first episode of seizure. 
In this study risk factors associated with status epilepticus are Intubation on arrival, 
decompensated shock, hypoglycaemia, acidosis, raised ICT. The above risk factors 
significantly affect the outcome of SE in children. Among them acidosis is the most common 
risk factor – 18 (19.6%). 
Out of 92 cases, in 15 cases (16.3%) seizure stopped with 1dose of IV diazepam and 
23 cases (25%) responded to 2nd doses of IV diazepam. In 48 cases (41.3%) seizure 
terminated with 2 doses of diazepam. 30 cases responded to IV Phenytoin. In10 cases seizure 
terminated with Phenobarbitone IV. Out of 14 cases seizure terminated with Midazolam 
1μgm/kg/min in  7 cases, Midazolam 2μgm/kg/min in 1 cases, Midazolam 3μgm/kg/min in 1 
cases, Midazolam 4μgm/kg/min in 5 cases. 
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In this study 15% (14 out of 92) had refractory SE and out of them, 7 survived and 5 
died. In the 7 cases survived with RSE, seizure controlled with minimum of Midazolam 
infusion 1μgm/Kg/min to maximum of 4μgm/Kg/min. Garson et al,56 study showed 11.3% 
incidence of RSE. In this study cases gone for RSE had poor outcome.   
The most common aetiology associated with status epilepticus in 92 children was 
remote causes 27.2% (25 cases), next being acute CNS infection 19.6% (18 cases), febrile 
seizure 18.5% (17 cases) and cryptogenic/idiopathic SD 16.3% (15 cases).Hui Ac et al, 
study59 shows that acute CNS infection was a predictor of poor outcome. Murthy JM et al60 
study shows CNS infection accounts for significant number of cases. 
In this study out of 92 cases, 74 cases (75.0%) recovered. Among those recovered, 5 
cases (5.5%) recovered with new neurological sequele; 13 cases (14%) died and 5 cases 
(5.5%) discharged against medical advice. 
Discussion onAnalysis of Outcome 
Out of 92 cases, 5 went on AMA and didn’t complete the study to know the outcome. 
So tsshe outcome of only 87 cases are analysed here.  
Table 2.1 explains the outcome across the various age groups. Of the total 87 patients 
74 (85.1%) have recovered and 13 (14.9%) have died. Almost the same proportion is 
maintained across the all age groups. So the age is not having significant association with the 
outcome (p- Value > 0.05). 
Table 2.2 explains the relationship between distance of travel and the outcome.  
Outcome is good among cases travelled less than 10 km and mortality is very low among 
children travelled less than 10 km. Mortality is very high among 12 children travelled more 
than 40 km. Out of 12 cases, 6 cases (50%) recovered and 6 cases (50%) died. It shows that 
lower the distance better the outcome and higher the distance higher bad outcome (death). 
The association is also statistically significant (p –Value < 0.05). . K. Eriksson, et al,45 study 
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concluded that the association between treatment delay and response became significant after 
30 minutes when this was analyzed as a single variable (p = 0.003). 
The above table 2.3 shows that the cases had prehospital therapy had poor outcome 6 
cases, (26.1%) than the case who didn’t receive prehospital therapy 7 cases(10.9%). But this 
difference is not statistically significant (p- value > 0.05). Those cases who received 
prehospital therapy had poor outcome (26.1%). This may be due the improper drug dosage at 
lower level hospitals and delayed referral. On contrary those who didn’t have prehospital 
therapy had come straight to the tertiary care hospital where appropriate management 
protocol is followed. Alldredge BK, et al61 data suggest that prehospital administration of 
diazepam may shorten the duration of SE in children and simplify the subsequent 
management of these patients in the emergency department. KL Kwong,et al62,also supports 
that BZD premedication reduces adverse outcome 
Table 2.4  shows that prolonged duration of the seizure before arrival to ER had poor 
outcome. This is also statistically significant (p- value <0.05). Gulati S,et al36 ,Karla Veena 
et al,58 also in their study found that seizure duration more than 45 minutes is significantly 
associated with higher mortality. KL Kwong,et al 62 study also supports that seizure duration 
more than 60 minutes had adverse outcome. Towne AR et al,51 the group with SE lasting < 1 
hour had a lower mortality as compared with seizure duration more than or equal to1 hour. 
From the table 2.6    it is observed that all the proportions of outcome are maintained almost 
equally in both the febrile and afebrile group. The difference is not statistically significant (p 
value > 0.005). 
Among the seizure type, death occurred in children with GTCS and NCSE. Out of 74 cases 
with GTCS 10 cases died and in NCSE 3 cases(50%) died out of 6 cases(100%).This shows 
that number of death among children with GTCS is common but in NCSE 3 cases(50%) died 
out of 6 cases(100%). Other studies also shows the same results. 
 
53 
 
If the seizure control is poor with initial first line AED, mortality is very high.In children 
receiving Midazolam infusion (3-4μgm/Kg/min) had poor outcome.   
Among the previously neurological abnormal children of 34 cases, 23.5% (8) cases 
had poor outcome. Only 9.4% (5) of the neurologically normal children (n=53) had poor 
outcome. But this different is not statistically significant (p- value >0.05). KL Kwong,et al62 
in his study observed Paediatric patients with status epilepticus who had normal 
neurodevelopmental status before the onset of an attack and who did not sustain an acute 
insult to the central nervous system or have progressive encephalopathy had good prognosis. 
From the table 2.8  the risk factors significantly affecting the outcome are hypoxia at the time 
of arrival, decompensated shock, respiratory failure requiring intubation and acidosis. (p- 
value <0.05). Kalra Veena et al,58 study showed presence of septic shock (p-0.001) were 
associated with significant mortality. 
 
FINAL OUTCOME 
Out of  92 case, 87 cases who completed the study, 74 cases recovered and 13 cases 
died due to varied etiology. All the febrile seizure cases presented as SE had good outcome. 
Acute CNS infection, remote causes, non compliance of AED, IEM, are the etiological 
factors influence the poor outcome. KL Kwong et al,62 study support the influence of 
etiological agents like symptomatic etiology, remote cause, refractory SE on the poor 
outcome. B G R Neville,et al,422 study conclude that febrile CSE is the commonest single 
group with a good prognosis in sharp distinction to CSE related to central nervous system 
infections which have a high mortality. 
Among 74 cases survived, 5 cases(6.7%) developed neurological sequele.3cases had 
GTCS, one had NCSE, and another one case had Focal to secondary generalisation.3 cases 
were less than 1year and 2 cases were more than 10 years among chidren developed 
sequele(Aphasia-2,Hemiparesis-1,Cognitive dysfunction-2). Out of 5 cases 4cases associated 
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with acidosis, one case associated with shock.Acute CNS infection (2 cases), Remote cause 
(2 cases) and AED Drug non compliance (1 case). Maytal J, et al54 study shows that new 
neurologic deficits were found in 17 (9.1%) of the 186 survivors. All of the deaths and 15 of 
the 17 sequele occurred in the 56 children with acute or progressive neurologic insults. Dunn 
W63 study 18 out of 114 cases developed neurological deficit and 11% in Simon J et al64 
study. 
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CONCLUSION 
 
1. Children with status epilepticus who had normal neurodevelopment status before the 
onset of an attack and who did not sustain an acute insult to the central nervous 
system, had favourable outcomes.  
2. The local population has restricted access to medical facilities and treatment before 
admission to our hospital is often inadequate. Seizures therefore last longer  before 
medical care is reached, and are thus more refractory to treatment. This factor might 
be more important. Duration and distance travelled to seek medical advice are also 
important risk factors that influencing the poor outcome. 
a)  Hence early institution of proper time framed therapy even by the nearest hospital 
will improve the outcome.Atleast proper prehospital therapy like the use of IM/IV 
midazolam or IV/ Rectal diazepam will have good outcome. 
 b) Airway stabilization with supplementary oxygen while transporting the child from 
periphery could result in better outcome in status epilepticus. 
3. Although the outcome is dependent on aetiology, appropriate early management along 
with specific AED therapy as per protocol may reduce some of the morbidity 
associated with CSE. 
4.  Acute CNS infection is one of the independent risk factor for poor outcome .Hence 
appropriate empirical antimicrobials to be given in a suspected case of acute CNS 
examination. All children should be routinely immunised for Hib, pneumococcal 
vaccines. 
5. Individual risk factors and complication to be anticipated and early intervention for 
complication like shock respiratory failure, aspiration, hypoglycemia or 
hyperglycemia, dyselectrolytemias to achieve good outcome. 
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6. Proper prehospital therapy, early referral, proper care while transporting, anticipating 
risk factors involved, and protocol based approach uniformly at all hospital can 
reduce the mortality due to status epilepticus in children. 
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SUMMARY 
 In this study Status epilepticus in children < 1year account for 22 cases 23.9 % of the 
total cases (n=92) and 54 cases 58.6 % out of the total cases were children < 5 years. 
Almost 60% of them were in the group < 5 years. 
 The mean age of the patient in the present study was 4.9 yrs.The youngest age being 2 
month. 
 Out of 92 children with SE both sex were equal in number. 
 Of the total 87 patients who completed the study 74 (85.1%) have recovered and 13 
(14.9%) have died. 
 Outcome is good among cases travelled less than 10 km and mortality is very low 
among children travelled less than 10 km. Mortality is very high among 12 children 
travelled more than 40 km. Out of 12 cases, 6 cases (50%) recovered and 6 cases 
(50%) died. 
 Those cases who had prehospital therapy had poor outcome (26.1%) than the case 
who didn’t receive prehospital therapy (7%). But this difference is not statistically 
 Prolonged duration of the seizure before arrival to Emergency Room had poor 
outcome. 
 Among the seizure type death occurred in children with GTCS and NCSE. Out of 74 
cases with GTCS 10 cases died and in NCSE 3 cases(50%) died out of 6 cases(100%). 
 If the seizure control is poor with initial first line AED, mortality is very high.In 
children receiving Midazolam infusion (3-4μgm/Kg/min) had poor outcome.   
 All the proportions of outcome are maintained almost equally in both the febrile and 
afebrile group. 
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 Among the previously neurological abnormal children of 34 cases, 23.5% (8) cases 
had poor outcome. Only 9.4% (5) of the neurologically normal children (n=53) had 
poor outcome 
 The risk factors significantly affecting the outcome are hypoxia at the time of arrival, 
decompensated shock, respiratory failure requiring intubation, hypoglycaemia and 
acidosis 
 87 children out of 92 cases who completed the study, 74 cases recovered and 13 cases 
died due to varied etiology. All the febrile seizure cases presented as SE had good if 
the seizure control is poor with initial first line AED, mortality is very high.In 
children receiving Midazolam infusion (3-4μgm/Kg/min) had poor outcome.  
outcome. Acute CNS infection, remote causes, non compliance of AED, IEM, are the 
etiological factors influence the poor outcome. 
 Among 87 cases, 5 cases developed neurological sequele.The most common 
etiological agents associated with sequele are acute CNS infection, Intra Cerebral 
haemorrhage, Idiopathic SD, remote cause. 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE PROFOMA 
 
Serial No : 
Hospital No : 
Ward Admitted : 
Name : 
Age : 
Sex :M/F 
Address 
Contact No : 
D. O. A 
D. O. D 
Time of arrival 
Referred From                    
1.Nil 
2.PHC 
3.GH 
4. Private Hospital 
5.OPD 
Distance from,TVMCH 
1. <5km 
2.5-10km 
3.10-20km 
4.21-40km 
5.>40km 
 
 
Mode of transport 
1.hand 
2.car 
3.auto 
4.twowheeler 
5.ambulance 
6.others 
Duration of seizures prior to reaching TVMCHin minutes 
Type of seizures 
1. GTCS 
2. Non convulsive 
3. Secondary generalisation 
4.others 
Number of attacks 
Duration : 
Risk factor:sleep deprivation/stress/trauma/toxindrugs/ 
Unprovoked/medical illness/others 
Level of sensorium in between attacks. ALOC/normal 
H /o ALOC before fits yes/no 
H/o head trauma:yes/no 
H/o toxin/drug ingestion:yes/no 
pre hospital therapy 
Drug and route of administration 
1.diazepam 
2.lorazepem 
 
 
3.phenytoin/phenobarbitone/midazolam. 
4.others. 
Past history 
h/o status epilepticus yes/no 
1.febrile/afebrile 
2.date of last episode. 
If yes date of occurance 
Duration  
On AED:   
Regular or not 
Dosage and duration 
Compliance: 
Last dose 
Development h/o normal delayed 
Neurological status before SE: normal /abnormal 
If abnormal specify 
Co-morbid condition 
1 
2 
3 
4 
Clinical examination 
Appearance : A/V/P/U 
Breathing : required BVM:   If yes/duration 
Required intubation : yes/no how long 
 
 
SPO2 on arrival 
Circulation shock yes or no 
If yes: compensated/decompensated 
BP on arrival: mmHg 
Required fluids/required ionotropes / uncorrected 
Pupil 
Blood sugar 
Management of seizures 
25% dextrose/lorazepam/BZD/phenytoin/phenobaritonrefractory seizure 
IN PICU 
Midazolam /thiopentone/others 
Rate of infusion 
shock:yes/no 
Time taken for full recovery of consciousness:              mins /hours 
Complication 
1.Acidosis 
2.pneumonia 
3.respiratort failure 
4.ICP 
5.Shock 
6.Hyperthermia 
7. neuroligal deficit 
8.Hypoglycaemia 
9.Hypocalcaemia 
 
 
 
Investigation 
Hb% 
Tc           dc           pcv 
Platelet /peripheral smear study sugar urea creatinine electrolyte LFT 
Blood culture 
Urine Metabolic Screening 
CXR 
CSF anlaysis   
USG cranium 
CT brain / MRI 
EEG  
Final diagnosis 
Outcome 
1. Recovered a) with or without sequele  
2.AMA 
3.Death  
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATION 
 
SE: STATUS EPILEPTICUS 
CSE: CONVULSIVE STATUS EPILEPTICUS 
RSE: REFRACTORY STATUS EPILEPTICUS 
NCSE: NON CONVULSIVE STATUS EPILEPTICUS 
ASE: ABSENT STATUS EPILEPTICUS 
PCSE: PARTIAL COMPLEX STATUS EPILEPTICUS 
IPPV: INTERMITTENT POSITIVE PRESSURE VENTILATION 
CNS: CENTRAL NERVOUS SYSTEM 
AED: ANTI EPILEPTIC DRUGS 
ACD: ANTI CONVULSANT DRUGS 
GABA: GAMMA AMINO BUTERIC ACID 
EEG: ELECTRO ENCEPHALOGRAM 
NMDA: N-METHYL D-ASPARTATE 
GTCS:  GENERALISED TONIC CLONIC SEIZURE 
CVA: CEREBRO VASCULAR ACCIDENT 
GCSE: GENERALISED COVULSIVE SE 
BZD: BENZODIAZEPINES 
LP: LUMBAR PUNCTURE 
PE : PHENYTOIN EQUIVALENT 
IV : INTRAVENOUS 
CXR : CHEST X-RAY 
CT: COMPUTED TOPOGRAPHY 
USG : ULTRA SONOGRAPHY 
 
 
ECG : ELECTRO CARDIOGRAPHY 
D.O.A. : DATE OF ADMISSION 
D.O.D. : DATE OF DISCHARGE 
TVMCH : TIRUNELVELI MEDICAL COLLEGE HOSPITAL 
ALOC : ALTERED LEVEL OF CONSCIOUSNESS 
IEM : INBORN ERROR OF METABOLISM 
ICP : INTRA CRANIAL PRESSURE 
PICU : PEDIATRIC INTENSIVE CARE UNIT 
A/V / P/U : A – ALERT, V – VERBAL, P – PAIN RESPONSIVE, U – UNCONSCIOUS 
BVM : BAG AND MASK VENTILATION 
BP : BLOOD PRESSURE 
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1 Abi 11 < 1 f self 0.5 30 GTCS febrile cns inf 2 bus nil nil n yes no 94 no no no 2. D2 NO NO NO a n - ACUTE CNS INFECTION RECOVERED
2 Isaki 27 1- 5 m self 9.0 30 GTCS afebrile cp 1 auto nil nil y yes no 92 no no no 3. P1 NO NO NO - - - REMOTE CAUSE RECOVERED
3 Durgaraj 24 1- 5 m self 8.0 40 GTCS febrile cns inf 2 auto nil nil n yes no 95 no no no 4. P2 NO NO NO a n - ACUTE CNS INFECTION RECOVERED
4 Chellamal 60 1- 5 f phc 55.0 180 GTCS febrile cn/res fail/shoc 2 amb nil nil n yes y 85 y l no 5. PH YES NO NO a n -
ACUTE CNS 
INFECTION EXPIRED
5 Mukesh 12 < 1 m self 0.8 30 GTCS febrile fever 2 car nil nil n yes no 94 no no no 2. D2 NO NO NO - - - FEBRILE SEIZURE RECOVERED
6 Uma 84 6-10 f pvt 0.5 30 FOCAL febrile fever 2 bike nil nil n yes no 97 no no no 2. D2 NO NO NO - - - FEBRILE SEIZURE RECOVERED
7 Yoga preethika 8 < 1 f pvt 20.0 60 GTCS febrile res fail/shoc 1 amb yes diazepam y yes y 88 y l no 3. P1 YES NO NO n n a I E METABOLISM EXPIRED
8 krishnaveni 24 1- 5 f gh 50.0 240 GTCS febrile add 2 amb yes diazepam n yes y 93 no no no 5. PH NO NO NO n n - ACUTE CNS INFECTION AMA
9 Md Basim 108 6-10 m pvt 13.0 72 GTCS febrile cns inf 2 amb yes phenytoin n yes no 94 no h no 4. P2 YES YES YES a n a ACUTE CNS INFECTION
RECOVERED -
S
10 Uma 84 6-10 f self 7.0 35 MULTI afebrile NO RISK 2 bike nil nil n yes no 96 no no no 4. P2 NO NO NO - - - IDIOPATHIC S D AMA
11 Monisha 8 < 1 f pvt 25.0 360 NCSE febrile add 1 car yes diazepam n yes y 85 no no no 9. M4 YES NO NO - n - REMOTE CAUSE EXPIRED
12 Ranganathan 2 < 1 m self 60.0 600 NCSE febrile cns inf 2 amb yes phenytoin n yes y 84 no no no 9. M4 NO NO NO a a - ACUTE CNS INFECTION EXPIRED
13 Mareshwari 36 1- 5 f pvt 50.0 180 GTCS febrile cns inf 2 amb yes diazepam n yes y 87 y no no 5. PH NO NO NO a a - ACUTE CNS INFECTION EXPIRED
14 Mahalakshmi 8 < 1 f self 7.0 30 GTCS febrile cns inf 2 bus nil nil n yes no 99 no no no 1. DI YES NO NO - - - FEBRILE SEIZURE RECOVERED
15 Priyan 84 6-10 m self 0.5 60 GTCS febrile cns inf 2 bike nil nil n yes no 97 no h no 3. P1 NO NO NO a a - ACUTE CNS INFECTION RECOVERED
16 Anad periyaswamy 132 > 10 m gh 8.0 30 GTCS afebrile all 2 amb nil nil n yes no 95 no no no 6. M1 YES NO NO - - - TUMOUR AMA
17 Aakash 21 1- 5 m self 0.8 40 GTCS febrile NO RISK 2 amb nil nil n yes y 96 no no no 5. PH NO NO NO - n - IDIOPATHIC S D RECOVERED
18 Kayamydeen 24 1- 5 m self 50.0 60 GTCS febrile asd/lri 2 amb nil nil n yes no 97 no no no 2. D2 NO NO NO - - - FEBRILE SEIZURE RECOVERED
19 Kasamadhan 36 1- 5 m self 0.5 30 GTCS febrile dd 1 amb nil nil y yes no 94 no no no 3. P1 NO NO NO - - - REMOTE CAUSE RECOVERED
20 Loganathan 48 1- 5 f self 5.0 40 GTCS febrile fever 1 amb yes diazepam n yes no 90 no h no 2. D2 YES YES YES - a - REMOTE CAUSE RECOVERED-S
21 Balashankar 72 6-10 m gh 6.0 35 focal-s afebrile NO RISK 1 amb nil nil n yes no 93 no h no 1. DI NO NO NO - a - REMOTE CAUSE RECOVERED
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22 Indu 120 6-10 f self 0.8 30 GTCS febrile known sd 2 amb nil nil y yes no 92 no no no 3. P1 NO NO NO - n - IDIOPATHIC S D RECOVERED
23 Diana epsiba 10 < 1 f pvt 8.0 35 GTCS febrile NO RISK 2 amb nil nil n yes no 96 no no no 2. D2 NO NO NO - - - IDIOPATHIC S D RECOVERED
24 Prema 120 6-10 f self 4.0 40 GTCS afebrile sturge weber 1 amb nil nil y yes no 95 no no no 4. P2 NO NO NO - a a
NEUROCUTANEOUS 
SYNDROME RECOVERED
25 Selvavani 12 < 1 m pvt 23.0 30 GTCS febrile cns inf 2 amb nil nil n yes no 94 no no no 3. P1 YES NO YES - a a IDIOPATHIC S D RECOVERED
26 Madhani 96 6-10 m gh 6.0 30 GTCS afebrile leukodystrophy 1 amb nil nil y yes no 96 no no no 2. D2 YES NO NO - - a I E METABOLISM RECOVERED
27 Muthusudali 108 6-10 m self 4.0 60 GTCS afebrile known sd 2 amb nil nil y yes no 95 no no no 3. P1 NO NO NO - - - IDIOPATHIC S D RECOVERED
28 Sumaiyabanu 60 1- 5 m self 5.0 30 GTCS febrile fever 2 car nil nil n yes no 99 no no no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
29 Mahendrakumar 48 1- 5 m self 0.5 35 GTCS febrile NO RISK 2 amb nil nil n yes no 90 no no no 2. D2 NO NO NO - - - IDIOPATHIC S D RECOVERED
30 Muthukannan 120 6-10 m gh 0.8 45 GTCS afebrile dd 1 amb nil nil y yes no 97 no no no 3. P1 NO NO NO - - - REMOTE CAUSE EXPIRED
31 Chinnathambi 8 < 1 m self 9.0 35 GTCS febrile cns inf 2 amb nil nil n yes no 94 no no no 3. P1 NO NO NO a a - ACUTE CNS INFECTION RECOVERED
32 Muthumani 120 6-10 m gh 12.0 32 GTCS afebrile dd 1 amb yes diazepam y yes no 92 no no no 2. D2 NO NO NO - - - REMOTE CAUSE RECOVERED
33 Essakiraj 72 6-10 m self 40.0 240 GTCS febrile cns inf 2 auto nil nil n yes y 84 y no no 9. M4 NO NO NO a a - ACUTE CNS INFECTION EXPIRED
34 Prathiba 108 6-10 f self 25.0 40 NCSE febrile cns inf 2 amb nil nil n yes no 95 no no no 3. P1 NO NO NO - a - NON COMPLIANCE RECOVERED
35 Muthukannan 11 < 1 m pvt 12.0 120 GTCS afebrile withdrawal 2 amb yes diazepam y yes no 96 no no no 2. D2 NO NO NO - - - NON COMPLIANCE RECOVERED
36 Murugeswari 11 < 1 f gh 20.0 35 GTCS febrile cns inf 2 bus yes diazepam n yes no 96 no no no 3. P1 NO NO NO a a - ACUTE CNS INFECTION RECOVERED
37 Saravan 18 1- 5 m gh 50.0 45 GTCS febrile fever 2 bike yes phenytoin n yes no 93 no no no 2. D2 NO NO NO - n - FEBRILE SEIZURE RECOVERED
38 Aswathi 12 < 1 f gh 25.0 120 GTCS febrile trauma 2 amb yes diazepam n yes no 92 no h no 4. P2 NO NO NO - n - TUMOUR RECOVERED
39 Ramalakshmi 96 6-10 f phc 45.0 300 NCSE febrile withdrawal/abscess 1 amb yes diazepam y yes y 87 no no no 8. M3 YES NO YES - - a NON COMPLIANCE EXPIRED
40 Kiruba 96 6-10 f self 50.0 240 GTCS febrile cns inf 2 amb yes diazepam n yes no 91 no no no 3. P1 NO NO NO a a - ACUTE CNS INFECTION
RECOVERED -
S
41 Viyalakshmi 72 6-10 f pvt 25.0 60 GTCS afebrile dd 1 amb nil nil y yes y 91 no no no 5. PH NO NO NO - - - REMOTE CAUSE RECOVERED
42 Manisheela 5 < 1 f phc 32.0 30 GTCS febrile dd/cp 1 amb nil nil y yes no 97 no no no 3. P1 NO NO NO - - - REMOTE CAUSE RECOVERED
43 Kangaraj 72 6-10 f self 12.0 30 GTCS febrile sd 2 amb nil nil y yes no 96 no no no 2. D2 NO YES NO - - - IDIOPATHIC S D RECOVERED
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44 Maharasi 5 < 1 f self 12.0 45 GTCS febrile
cns 
inf/septic 
shock/rf
2 amb nil nil n yes y 80 y l no 2. D2 YES NO NO a a - ACUTE CNS INFECTION RECOVERED
45 Darshini 60 1- 5 f self 30.0 480 GTCS febrile cns inf 1 amb nil nil n yes no 94 y no no 6. M1 YES NO NO - - - REMOTE CAUSE EXPIRED
46 Esakkimuthu 33 1- 5 m self 20.0 30 GTCS febrile fever 2 car nil nil n yes no 93 no no no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
47 Sheeba 120 6-10 f self 7.0 30 GTCS febrile dd 1 bus nil nil y yes no 92 no no no 1. DI NO YES NO - a - REMOTE CAUSE RECOVERED
48 Agitha 132 > 10 f gh 60.0 240 GTCS afebrile
res 
fail/shock/t
rauma
1 amb yes phenytoin n yes y 85 y l no 5. PH NO NO NO - - - REMOTE CAUSE EXPIRED
49 Mariya deepa 48 1- 5 f phc 32.0 30 GTCS afebrile withdrawal 1 amb nil nil y yes no 94 no no no 6. M1 NO NO NO - - - REMOTE CAUSE RECOVERED
50 Shakthi 36 1- 5 f self 0.5 30 GTCS febrile dd 1 bus nil nil y yes no 93 no l no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
51 Swetha 96 6-10 f self 0.8 35 GTCS febrile cns inf 2 amb nil nil n yes no 96 no no no 2. D2 NO NO NO - - - FEBRILE SEIZURE RECOVERED
52 Manibarathy 108 6-10 m gh 3.0 45 GTCS afebrile sd 2 amb nil nil y yes no 96 no no no 3. P1 NO NO NO - - - IDIOPATHIC S D RECOVERED
53 Yesuraja 12 < 1 m gh 30.0 30 GTCS febrile dd/fever 1 amb nil nil y yes no 96 no l no 3. P1 NO YES NO - - - FEBRILE SEIZURE RECOVERED
54 Subithra 3 < 1 f self 30.0 45 FOCAL afebrile cns hage 2 amb nil nil n yes no 94 no no no 6. M1 NO NO NO - a a CNS HEMORRHAGE RECOVERED -S
55 Kandaiselvi 21 1- 5 f gh 10.0 30 GTCS febrile fever 2 amb nil nil n yes no 94 no no no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
56 Selvi 36 1- 5 f self 0.5 40 GTCS febrile aspiration 2 amb nil nil n yes y 90 no no no 2. D2 NO NO NO - - - IDIOPATHIC S D RECOVERED
57 Veerapandian 48 1- 5 m pvt 24.0 35 GTCS febrile dd 1 amb nil nil y yes no 97 no no no 1. DI NO NO NO - - - REMOTE CAUSE RECOVERED
58 Essakimuthuraman 84 6-10 m pvt 7.0 30 GTCS afebrile NO RISK 2 amb nil nil n yes no 93 no no no 2. D2 NO NO NO - a - IDIOPATHIC S D RECOVERED
59 Krishnamoorthy 132 > 10 m gh 42.0 45 GTCS febrile cns inf 1 amb yes phenytoin n yes y 93 no l no 5. PH NO NO NO - a - REMOTE CAUSE RECOVERED
60 Preethika 8 < 1 f self 23.0 35 GTCS febrile cns inf 2 amb nil nil n yes no 94 no no no 2. D2 YES NO NO n n - ACUTE CNS INFECTION RECOVERED
61 Bathrakali 3 < 1 m gh 6.0 45 GTCS febrile
cns 
inf/septic 
shock/rf
2 amb yes pheno n yes y 86 y no no 5. PH NO NO NO a a - ACUTE CNS INFECTION RECOVERED
62 Mariadeepa 48 1- 5 f self 50.0 35 GTCS febrile cp 1 amb nil nil y yes no 93 no l no 1. DI YES NO NO - - - REMOTE CAUSE EXPIRED
63 Durgadevi 48 1- 5 f self 20.0 180 GTCS febrile cns hage 2 amb nil nil n yes no 95 no h no 4. P2 NO NO NO - a a CNS HEMORRHAGE RECOVERED
64 Ponmadaswamy 96 6-10 m self 15.0 35 GTCS febrile NO RISK 2 amb nil nil n yes no 96 no no no 2. D2 YES NO NO - - - IDIOPATHIC S D EXPIRED
65 Karthikannan 72 6-10 m self 45.0 45 GTCS febrile fulminant hepatitis 2 amb nil nil n yes no 95 no no no 2. D2 NO YES NO - a - SYSTEMIC ILLNESS RECOVERED
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66 Manju 11 < 1 f self 12.0 35 GTCS febrile cns inf 2 amb nil nil n yes y 88 no no no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
67 Nishanthipriya 84 6-10 f self 6.0 40 GTCS febrile cns inf 2 amb nil nil n yes no 96 no h no 2. D2 NO NO NO - - - FEBRILE SEIZURE RECOVERED
68 Gowri 36 1- 5 f gh 32.0 35 GTCS febrile fever 2 amb nil nil n yes y 90 no h no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
69 Vinojayaraj 72 6-10 m phc 25.0 30 GTCS febrile pms 1 amb nil nil y yes no 96 no no no 4. P2 NO NO NO - - - REMOTE CAUSE RECOVERED
70 Radha 72 6-10 f self 12.0 45 GTCS afebrile withdrawal 1 amb nil nil y yes no 97 no no no 3. P1 YES NO NO - - - REMOTE CAUSE EXPIRED
71 Gaythri 36 1- 5 f gh 45.0 480 GTCS febrile cns inf 2 amb nil nil n yes y 88 no l no 9. M4 NO NO NO a n - ACUTE CNS INFECTION RECOVERED
72 Helenanushya 24 1- 5 f self 8.0 45 GTCS afebrile NO RISK 2 amb nil nil n yes no 96 no h no 9. M4 NO NO NO - - - IDIOPATHIC S D RECOVERED
73 Madaswamy 48 1- 5 m self 12.0 30 GTCS febrile lri 2 amb nil nil n yes no 97 no h no 1. DI NO NO NO - - - SYSTEMIC ILLNESS RECOVERED
74 Karthikannan 48 1- 5 m self 25.0 40 GTCS febrile dd/cns inf 1 amb nil nil y yes no 94 no no no 2. D2 NO NO NO - - - REMOTE CAUSE RECOVERED
75 Mahalakshmi 24 1- 5 f self 25.0 35 GTCS febrile fever 2 amb nil nil n yes no 94 no no no 1. DI YES NO NO - - - FEBRILE SEIZURE RECOVERED
76 Veerapandian 54 1- 5 m pvt 4.0 30 GTCS febrile dd 1 amb yes diazepam y yes no 93 no no no 4. P2 NO NO NO - a - REMOTE CAUSE RECOVERED
77 Hema 120 6-10 f gh 21.0 45 GTCS febrile migraine 2 amb yes diazepam n yes no 98 no no no 1. DI NO NO NO - a - IDIOPATHIC S D RECOVERED -S
78 Lakshmi 8 < 1 f self 35.0 45 GTCS febrile add/adem 2 amb nil nil n yes y 99 no no no 5. PH NO NO NO n n - ACUTE CNS INFECTION RECOVERED
79 Karthik 96 6-10 m self 25.0 35 focal-s afebrile dd/cp 1 amb nil nil y yes no 96 no no no 3. P1 NO NO YES - a - REMOTE CAUSE RECOVERED -S
80 Thalavai 132 > 10 m pvt 34.0 180 FOCAL afebrile dd 1 amb yes diazepam y yes no 94 no no no 3. P1 NO NO NO - a - REMOTE CAUSE RECOVERED
81 Ponpandi 132 > 10 m self 7.0 30 GTCS febrile cns inf 2 amb nil nil n yes no 90 no no no 3. P1 NO NO NO a a - ACUTE CNS INFECTION RECOVERED
82 Ramlakshmi 36 1- 5 f self 25.0 35 NCSE febrile lri 2 amb nil nil n yes no 91 no no no 3. P1 NO NO NO n a - SYSTEMIC ILLNESS RECOVERED
83 Sofya 24 1- 5 f self 35.0 38 GTCS afebrile hemiplegia 1 amb nil nil y yes no 92 no no no 6. M1 NO NO NO - a - REMOTE CAUSE RECOVERED
84 Shanmugaraja 12 < 1 m self 25.0 30 FOCAL febrile fever 2 amb nil nil n yes no 91 no no no 1. DI NO NO NO - - - FEBRILE SEIZURE RECOVERED
85 Anush 12 < 1 m pvt 15.0 35 GTCS febrile dd 1 amb yes diazepam y yes no 90 no h no 2. D2 NO NO NO n - - FEBRILE SEIZURE RECOVERED
86 Maharajan 30 1- 5 m self 14.0 120 GTCS afebrile cp 1 amb yes phenytoin y yes no 92 no no no 7. M2 NO NO NO - a - REMOTE CAUSE RECOVERED
87 Gopalakrishan 48 1- 5 m self 6.0 45 FOCAL febrile dd 1 amb yes diazepam y yes y 94 no no no 5. PH NO NO NO - a - NEUROCUTANEOUS SYNDROME RECOVERED
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88 Iswarya 84 6-10 m self 25.0 50 GTCS afebrile withdrawal 2 amb nil nil y yes no 92 no no no 3. P1 NO NO NO - - - NON COMPLIANCE RECOVERED
89 Ulaganathan 72 6-10 m self 15.0 60 NCSE afebrile dd/cp 1 amb nil nil y yes no 94 no no no 2. D2 NO NO NO - a a NON COMPLIANCE RECOVERED
90 Essakimuthuraman 108 6-10 m gh 6.0 60 GTCS afebrile cp 1 amb yes diazepam y yes no 92 no h no 6. M1 NO NO NO - - - REMOTE CAUSE RECOVERED
91 Manikandan 132 > 10 m gh 8.0 30 GTCS afebrile all 2 amb nil nil n yes no 95 no no no 6. M1 YES NO NO - - - TUMOUR AMA
92 Loothu 84 6-10 f self 7.0 35 MULTI afebrile NO RISK 2 bike nil nil n yes no 96 no no no 4. P2 NO NO NO - - - IDIOPATHIC S D AMA
Abbreviations
M Male
F Female
CP Cerebral Palsy
DD Development Delay
amb Ambulance
y yes
n no
D1 Diazepam first dose
D2 Diazepam Second dose
P1 Phenytoin first dose
P2 Phenytoin second dose
PH Phenobarbitone
M1 Midazolam 1microgram / kg / min
M2 Midazolam 2microgram / kg / min
M3 Midazolam 3microgram / kg / min
M4 Midazolam 4microgram / kg / min
gh Government Hospital
pvt Private Hospital
phc Primary Health Centre
CNS inf Central Nervous system Infection
a abnormal
n normal
1 Neurologicaly abnormal
2 Neurologically normal
Recovered - S Recovered with Sequele
